Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,468 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $649.79 | 7 | $0 (2021) |
| Gilead Sciences, Inc. | $612.88 | 5 | $0 (2019) |
| AbbVie, Inc. | $530.11 | 4 | $0 (2019) |
| QOL Medical, LLC | $299.99 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $131.00 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $123.95 | 1 | $0 (2018) |
| ALCRESTA THERAPEUTICS, INC. | $119.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $131.00 | 1 | E.R. Squibb & Sons, L.L.C. ($131.00) |
| 2021 | $438.07 | 4 | QOL Medical, LLC ($299.99) |
| 2020 | $125.00 | 1 | Merck Sharp & Dohme Corporation ($125.00) |
| 2019 | $895.72 | 8 | AbbVie, Inc. ($395.31) |
| 2018 | $495.04 | 4 | Gilead Sciences, Inc. ($249.98) |
| 2017 | $382.82 | 3 | AbbVie, Inc. ($134.80) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $131.00 | General |
| Category: Neuroscience | ||||||
| 10/21/2021 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/21/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | In-kind items and services | $175.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/29/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/23/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO, ZINPLAVA | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/04/2020 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/12/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $133.13 | General |
| Category: Virology | ||||||
| 04/22/2019 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $112.92 | General |
| Category: HCV | ||||||
| 03/28/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Virology | ||||||
| 03/14/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/07/2019 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 02/01/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/31/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $144.34 | General |
| Category: Virology | ||||||
| 08/07/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $121.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: HBV | ||||||
| 03/12/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 03/09/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $123.95 | General |
| Category: VACCINES | ||||||
| 07/27/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 02/16/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $134.80 | General |
| Category: Virology | ||||||
About Dr. Mark Siegel, M.D
Dr. Mark Siegel, M.D is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013981380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Siegel, M.D has received a total of $2,468 in payments from pharmaceutical and medical device companies, with $131.00 received in 2023. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($2,468).
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 02/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1013981380
Products in Payments
- DIFICID (Drug) $401.75
- Mavyret (Drug) $395.31
- Epclusa (Drug) $362.92
- SUCRAID (Drug) $299.99
- ZINPLAVA (Biological) $248.04
- Viekira (Drug) $134.80
- ZEPOSIA (Drug) $131.00
- Vemlidy (Drug) $124.98
- SHINGRIX (Biological) $123.95
- RELIZORB (Device) $119.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554